Internal Medicine, Infectious Disease · Valdosta, GA
NPI
1922419928
Since 2014
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2418 N Oak St Ste B2
Valdosta, GA, 31602
Phone (229) 433-1838
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
493 services
Medicare patients, 2024
155
Average age 73
Drug cost, 2024
$1.8M
921 prescriptions
Company payments, 2025
$63.76
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rita E Medina was code 99233 (hospital e&m - subsequent), 158 times for 68 patients. In total Rita E Medina billed 493 services in 11 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 158 | 68 | $88.50 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 113 | 55 | $59.46 | $6,719 |
| 99223 Hospital E&M - Initial | Facility | 90 | 87 | $127.46 | $11K |
| 99214 Office E&M - Established | Office | 55 | 33 | $88.44 | $4,864 |
| 99222 Hospital E&M - Initial | Facility | 30 | 28 | $98.75 | $2,962 |
| 99291 Critical Care E&M | Facility | 14 | 11 | $158.20 | $2,215 |
By year: 2022 $63K for 653 services; 2023 $62K for 678 services; 2024 $45K for 493 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rita E Medina prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 188 prescriptions and refills. In total Rita E Medina wrote 921 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 188 | 188 | 21 | $779K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 129 | 132 | 14 | $509K |
| Daptomycin Generic | 62 | 62 | 17 | $47K |
| Ceftriaxone Ceftriaxone Sodium | 48 | 48 | 14 | $1,942 |
| Atazanavir Sulfate Generic | 34 | 38 | Under 11 | $33K |
| Doxycycline Hyclate Generic | 33 | 69 | 12 | $1,898 |
| Ertapenem Ertapenem Sodium | 31 | 31 | 17 | $8,859 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 29 | 43 | Under 11 | $45K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 | 65 | 11 | $841 |
| Amikacin Sulfate Generic | 26 | 26 | Under 11 | $1,431 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 23 | 23 | Under 11 | $90K |
| Tivicay Dolutegravir Sodium | 18 | 18 | Under 11 | $41K |
| Ritonavir Generic | 18 | 20 | Under 11 | $3,633 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 16 | 18 | Under 11 | $406 |
| Prezcobix Darunavir/Cobicistat | 13 | 13 | Under 11 | $31K |
Brand drugs: 429 claims; generic drugs: 492 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rita E Medina $63.76 ($63.76 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $27.16.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $27.16 |
| Paratek Pharmaceuticals, Inc. | 1 | $21.6 |
| bioMerieux Inc | 1 | $15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.